Original ResearchOpen Access

Effect of staurosporine and ucn-01 on gemcitabine cytotoxicity in relation to cell cycle effects and p53 status

GJ Peters, J Sigmond, LG Leon, JAE Kamphuis, AM Bergman
Applied Scientific Reports 2012 1 : 29 ( 29 October 2012 )
Case reportOpen Access

Primary isolated bone marrow diffuse large B-cell lymphoma with the initial presentation as severe thrombocytopenia, successfully treated with chemotherapy: a case report and review of the literature

Hiroko Nishida, Masao Hori, Katsuyuki Obara
Applied Scientific Reports 2012 1 : 28 ( 15 October 2012 )
Original ResearchOpen Access

Prognostic Factors after Curative Resection of Pancreatic Ductal Adenocarcinoma: a Retrospective Study

Ilze Strumfa, Zane Simtniece, Arnis Abolins, Andrejs Vanags, Janis Gardovskis
Applied Scientific Reports 2012 1 : 27 ( 13 October 2012 )
Original ResearchOpen Access

The optimization of transfection in MCF-7 cells combining ultrasound irradiation with contrast agent and polyethyleneimine

Zhi-Yi Chen, Ri-Xiang Qiu, Xiao-Fang Sun, Kun Liang, Jin-Shan Zhang, Yan Lin, Feng Yang
Applied Scientific Reports 2012 1 : 26 ( 6 October 2012 )

Cancer Stem Cells

Journal of Cancer Therapetics & Research Open access Journal covers special section Cancer stem cells aims to publish research on identification, characterization and isolation of cancer stem cells in various cancer types, metastatic mechanisms, surface markers and their role in cancer initiation, progression and maintenance. The scope of the section includes reviews, hypothetical theories, clinical practices and novel techniques in regulating cancer stem cells.

Innovative Therapies

Journal of Cancer Therapetics & Research Open access Journal covers special section Innovative Therapies focuses on the treatment and prevention of cancer. This section inculdes cancer curing therapies and pharmaceutical applications with the study of anti-cancer drugs, therapeutic agents and Drug Development based on the signalling mechanisms and pharmacodynamics.

Carcinogenesis

Journal of Cancer Therapetics & Research Open access Journal contains special section Carcinogenesis covers the study of cells undergoing carcinogenesis with uncontrolled mutagenesis. It includes every aspect of biochemical mechanisms in relation to the cancer development. Also the focus is on medicinal research from diagnostic testing to monitoring of tumor progression through modulating agents and molecular epidemiology, examination of cells and tissues.

Organ Specific Cancers

Journal of Cancer Therapetics & Research Open access Journal covers special section Organ Specific Cancers, With its heterogenetic ability, Cancer has a diversified nature in relation to the organ specificity. This section encompasses study of cancer dvelopment in different organs and their transition among the organs. The primary focus is on heterogeneity, origin, metastasis, angiogenesis and organ specified mechanisms in cancer cells.

Radiation And Imaging

Journal of Cancer Therapetics & Research Open access Journal covers special section Radiation and Imaging section includes medical diagnostic procedures and treatment using radiation, chemotherapy and imaging technology. It focuses on the modified therapeutic strategies to control cancer and implementing preventional methods.

Epidemiology, Genetics And Genomics

Journal of Cancer Therapetics & Research Open access Journal covers special section Epidemiology Genetics and Genomics aim to attract papers in the field of epidemiology, genetics and genomics in cancer cells and cancer patients. Understanding the cancer genetics, gene expression and regulation in cancer cells, their heterogeneity will give new insights in diagnosis and treatment. The section intend to disseminate information and knowledge that may furnish novel applications such as personalized treatment with either DNA or protein kinase targeted drugs, combinations with modern radiotherapeutic approaches. The section also considers studies performing whole genome sequencing to recognize potential drug targets or limited for selected genes to identify patients responding to particular treatments more likely.